Contraceptive effectiveness of two spermicides: A randomized trial

Obstetrics and Gynecology

Volumn 93, Issue 6, 1999, Pages 896-903

  Raymond, Elizabeth ^a   Dominik, Rosalie ^b  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NONOXINOL 9; SPERMICIDAL AGENT; UNCLASSIFIED DRUG; VCF VAGINAL CONTRACEPTIVE FILM;

ADULT; ARTICLE; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; DOSAGE FORMS; FEMALE; HUMANS; NONOXYNOL; PREGNANCY; SPERMATOCIDAL AGENTS;

EID: 0033036106     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(99)00002-2     Document Type: Article

References (17)

1. Trussell J. Contraceptive efficacy. In: Hatcher RA, Trussell J, Stewart F, Stewart GK, Kowal D, Guest F, et al, eds. Contraceptive technology, 17th rev ed. New York: Irvington Publishers, 1998: 779-844.
2. Cates VV Jr, Raymond EG. Vaginal spermicides. In: Hatcher RA, Trussell J, Stewart F, Stewart GK, Kowal D, Guest F, et al, eds. Contraceptive technology, 17th rev ed. New York: Irvington Publishers, 1998:357-69.
3. Roddy RE, Schulz KF, Cates VV Microbicides, meta-analysis, and the N-9 question-where's the research? Sex Transm Dis 1998;25: 151-3.
4. Potts M. The urgent need for a vaginal microbicide in the prevention of HIV transmission. Am J Public Health 1994;84:890-1.
5. Steiner M, Spruyt A, Joanis C, Glover L, Cordero M, Alvarado G, et al. Acceptability of spermicidal film and foaming tablets among women in three countries. Int Fam Plann Perspect 1995;21:104-7.
6. Federal Register. Vaginal contraceptive drug products for overthe-counter human use. Department of Health and Human Services. Food and Drug Administration, 21 CFR Part 310. 1995;60: 6892-902.
7. Lachin JM, Foulkes MA. Evaluation of sample size and power analysis of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. Biometrics 1986/42:507-19.
8. Kaplan EL, Meier P. Nonparametrics estimation from incomplete observations. J Am Stat Assn 19583:457-81.
9. Cox DR. Regression models and life tables (with discussion). J R Stat Soc Series B 19724:187-220.
10. Koch GG, Atkinson SS, Stokes ME. Poisson regression. In: Kotz S, Johnson NL, eds. Encyclopedia of statistical sciences, 7th ed. New York: John Wiley and Sons, 1986:32-41.
11. Trussell J, Sturgen K, Strickler J, Dominik R. Contraceptive efficacy of the Reality female condom: Comparison with other barrier methods. Farn Plann Perspect 1994;26:266-72.
12. Lamptey P, Klufio C, Smith S, Feldblum P. A comparative study of Neosampoon, Ortho vaginal tablets and Emko vaginal tablets in Accra, Ghana. Contraception 198532:445-54.
13. Chompootaweep S, Dusitsin N. A comparative study of the safety, effectiveness and acceptability of two foaming vaginal tablets (nonoxynol-9 versus menfegol) in Thai women. Contraception 1990;41:507-17.
14. Brigato G, Pisano G, Bergamasco A, Pasqualini M, Cutugno G, Luppari T. Vaginal topical chemical contraception with C-film. Ginecol Clinica 1982:77-80.
15. lizuka R, Kobayashi T, Kawakami S, Nakamura Y, Ikeuchi M, Chin B, et al. Clinical experience with the vaginal contraceptive film containing the spermicide polyoxyethylene nonylphenyl ether (C-film study group). Jpn J Fertil Steril 1980;25:64-8.
16. Dingle JT, Teitze C. Comparative study of three contraceptive methods: Vaginal foam tablets, jelly alone, and diaphragm with jelly or cream. Am J Obstet Gynecol 1963;85:1012-22.
17. Mauck C, Glover LH, Miller E, Alien S, Archer DF, Blumenthal P, et al. Lea's shield: A study of the safety and efficacy of a new vaginal barrier contraceptive used with and without spermicide. Contraception 1996;53:329-35.